SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Renal Hypouricemia
The SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for kidney and metabolic disorders. This advanced genetic test specifically targets the SLC2A9 gene, which plays a critical role in uric acid transport and renal function. Using state-of-the-art Next-Generation Sequencing technology, our test provides unparalleled accuracy in detecting genetic mutations associated with renal hypouricemia type 2, enabling precise diagnosis and personalized treatment strategies.
What This Test Measures and Detects
Our comprehensive genetic analysis focuses on identifying specific mutations in the SLC2A9 gene that disrupt normal uric acid handling by the kidneys. The test examines:
- Complete sequencing of the SLC2A9 gene coding regions
- Detection of point mutations, insertions, and deletions
- Identification of pathogenic variants affecting uric acid transporter function
- Assessment of genetic predisposition to renal hypouricemia
- Evaluation of inheritance patterns for genetic counseling
Who Should Consider This Genetic Test
This specialized genetic test is recommended for individuals experiencing:
- Unexplained persistently low serum uric acid levels
- Recurrent kidney stone formation despite normal uric acid
- Family history of renal hypouricemia or kidney disorders
- Exercise-induced acute kidney injury episodes
- Unexplained renal dysfunction with metabolic abnormalities
- Patients with suspected inherited renal transport defects
Clinical Benefits of Genetic Testing
Undergoing the SLC2A9 genetic test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out genetic causes of renal hypouricemia
- Personalized Treatment: Enables targeted therapeutic interventions
- Family Planning: Provides crucial information for genetic counseling
- Early Intervention: Facilitates proactive management of potential complications
- Comprehensive Care: Supports multidisciplinary approach involving nephrology, endocrinology, and genetics specialists
Understanding Your Test Results
Our genetic specialists provide comprehensive interpretation of your results:
- Positive Result: Indicates presence of pathogenic SLC2A9 mutations confirming renal hypouricemia type 2 diagnosis
- Negative Result: Suggests alternative causes for clinical symptoms should be investigated
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important for family planning and genetic counseling purposes
All results include detailed explanations and recommendations for next steps in consultation with your healthcare provider.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Availability
We have conveniently located testing centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent quality and reliable results nationwide.
Take Control of Your Health Today
Don’t let unexplained symptoms or family history concerns go unaddressed. Our SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With results available in just 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient.
Ready to schedule your genetic test? Contact our genetic counseling team at +1(267) 388-9828 or book your appointment online today. Our specialists are available to answer your questions and guide you through the testing process.
